The Biorepository and Laboratory Services (BLS) sunrise plan has been approved and BLS has resumed some operations.
- BioNet specimen procurement will be on-site to collect specimens from cases that are part of ongoing clinical trials. Unfortunately, BioNet is not able to consent patients for targeted collections during this initial stage. We are exploring alternative methods of consenting, such as universal consent and remote consent.
- The BLS repository staff will be on-site for specimen management as needed.
- The BLS histology lab will be resuming 50% of their operations.
Please direct any questions to Joe Menth, interim BLS program director, [email protected].
Thank you for your patience as we work through our sunrise plan.